Evidence map›Paper›PMID 33456347›Full record

ArticleInternational journal of medical sciences2021

Effect of lentivirus-mediated miR-182 targeting FGF9 on hallux valgus.

Wei-Lin Zhang, Duo-Yi Zhao, Wei Zhao, Yan Cui, Qin Li, Zhi-Yu Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis.Analytical cellular pathology (Amsterdam) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wei-Lin ZhangDepartment of Orthopedics, the Fourth Affiliated Hospital of China Medical University, No.4 East Chongshan Road, Shenyang, 110032, P.R. China.
Duo-Yi ZhaoDepartment of Orthopedics, the Fourth Affiliated Hospital of China Medical University, No.4 East Chongshan Road, Shenyang, 110032, P.R. China.
Wei ZhaoDepartment of Orthopedics, the Fourth Affiliated Hospital of China Medical University, No.4 East Chongshan Road, Shenyang, 110032, P.R. China.
Yan CuiDepartment of Orthopedics, the Fourth Affiliated Hospital of China Medical University, No.4 East Chongshan Road, Shenyang, 110032, P.R. China.
Qin LiCenter for Translational Medicine, the Fourth Affiliated Hospital of China Medical University, No.4 East Chongshan Road, Shenyang, 110032, P.R. China.
Zhi-Yu ZhangDepartment of Orthopedics, the Fourth Affiliated Hospital of China Medical University, No.4 East Chongshan Road, Shenyang, 110032, P.R. China.
Fourth Affiliated Hospital of China Medical University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of hallux valgus is not clearly understood. However, genetics research about hallux valgus is rare. Therefore, the present study aimed to explore the pathogeny of hallux valgus from the perspective of genetics. Human samples were collected from normal bone tissue and hallux valgus region bone tissue. The bone samples were studied using real time-PCR, western blot and immunohistochemical. Lentivirus-mediated miR-182 transfected osteoblasts and tested the expression of FGF9 mRNA with real time-PCR. To test alkaline phosphatase activity, number of calcium nodules and proliferation of osteoblast with enzymatic activity analysis, calcium nodules stained and MTT assay. We found that (1) FGF9 expressed in hallux valgus region bone tissue was significantly higher than normal bone tissue. (2) miR-182 expression levels in hallux valgus region bone tissue were notably lower than those of normal bone tissue. (3) miR-182 could negatively regulate the expression of FGF9 in osteoblasts. (4) FGF9 may enhance osteoblasts proliferation. We have demonstrated that miR-182 promotes the formation of bone by targeting FGF9, implicating an essential role of miR-182 in the etiology of hallux valgus. Moreover, miR-182 might potentially be a therapeutic target for hallux valgus treatment.

Indexed as

AdultAgedBone and BonesCase-Control StudiesCell DifferentiationCell LineCell ProliferationFemaleFibroblast Growth Factor 9Gene Knockdown TechniquesGenetic VectorsHallux ValgusHumansLentivirusMaleMicroRNAsFGF9 protein, humanFibroblast Growth Factor 9MicroRNAsMirn182 microRNA, humanalkaline phosphataseFGF9hallux valgusmiR-182osteoblast

Identifiers

PMID33456347
PMCPMC7807199
OpenAlexW3118641273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.